246 related articles for article (PubMed ID: 23589865)
1. Engineering of TEV protease variants by yeast ER sequestration screening (YESS) of combinatorial libraries.
Yi L; Gebhard MC; Li Q; Taft JM; Georgiou G; Iverson BL
Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7229-34. PubMed ID: 23589865
[TBL] [Abstract][Full Text] [Related]
2. Yeast Endoplasmic Reticulum Sequestration Screening for the Engineering of Proteases from Libraries Expressed in Yeast.
Yi L; Taft JM; Li Q; Gebhard MC; Georgiou G; Iverson BL
Methods Mol Biol; 2015; 1319():81-93. PubMed ID: 26060071
[TBL] [Abstract][Full Text] [Related]
3. Profiling Protease Specificity: Combining Yeast ER Sequestration Screening (YESS) with Next Generation Sequencing.
Li Q; Yi L; Hoi KH; Marek P; Georgiou G; Iverson BL
ACS Chem Biol; 2017 Feb; 12(2):510-518. PubMed ID: 27977123
[TBL] [Abstract][Full Text] [Related]
4. YESS 2.0, a Tunable Platform for Enzyme Evolution, Yields Highly Active TEV Protease Variants.
Denard CA; Paresi C; Yaghi R; McGinnis N; Bennett Z; Yi L; Georgiou G; Iverson BL
ACS Synth Biol; 2021 Jan; 10(1):63-71. PubMed ID: 33401904
[TBL] [Abstract][Full Text] [Related]
5. Modular and integrative activity reporters enhance biochemical studies in the yeast ER.
Martinusen SG; Slaton EW; Nelson SE; Pulgar MA; Besu JT; Simas CF; Denard CA
Protein Eng Des Sel; 2024 Jan; 37():. PubMed ID: 38696722
[TBL] [Abstract][Full Text] [Related]
6. Engineering of TEV protease variants with redesigned substrate specificity.
Meister SW; Parks L; Kolmar L; Borras AM; Ståhl S; Löfblom J
Biotechnol J; 2023 Nov; 18(11):e2200625. PubMed ID: 37448316
[TBL] [Abstract][Full Text] [Related]
7. Screening of Yeast Display Libraries of Enzymatically Treated Peptides to Discover Macrocyclic Peptide Ligands.
Bowen J; Schneible J; Bacon K; Labar C; Menegatti S; Rao BM
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562883
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Analysis of the Substrate Specificity of Human Rhinovirus 3C Protease and Exploration of Its Substrate Recognition Mechanisms.
Fan X; Li X; Zhou Y; Mei M; Liu P; Zhao J; Peng W; Jiang ZB; Yang S; Iverson BL; Zhang G; Yi L
ACS Chem Biol; 2020 Jan; 15(1):63-73. PubMed ID: 31613083
[TBL] [Abstract][Full Text] [Related]
9. A tobacco etch virus protease with increased substrate tolerance at the P1' position.
Renicke C; Spadaccini R; Taxis C
PLoS One; 2013; 8(6):e67915. PubMed ID: 23826349
[TBL] [Abstract][Full Text] [Related]
10. Engineering a novel endopeptidase based on SARS 3CL(pro).
Kuo CJ; Shih YP; Kan D; Liang PH
Biotechniques; 2009 Dec; 47(6):1029-32. PubMed ID: 20041855
[TBL] [Abstract][Full Text] [Related]
11. Efficient site-specific processing of fusion proteins by tobacco vein mottling virus protease in vivo and in vitro.
Nallamsetty S; Kapust RB; Tözsér J; Cherry S; Tropea JE; Copeland TD; Waugh DS
Protein Expr Purif; 2004 Nov; 38(1):108-15. PubMed ID: 15477088
[TBL] [Abstract][Full Text] [Related]
12. Structural determinants of tobacco vein mottling virus protease substrate specificity.
Sun P; Austin BP; Tözsér J; Waugh DS
Protein Sci; 2010 Nov; 19(11):2240-51. PubMed ID: 20862670
[TBL] [Abstract][Full Text] [Related]
13. Highly active and selective endopeptidases with programmed substrate specificities.
Varadarajan N; Rodriguez S; Hwang BY; Georgiou G; Iverson BL
Nat Chem Biol; 2008 May; 4(5):290-4. PubMed ID: 18391948
[TBL] [Abstract][Full Text] [Related]
14. The P1' specificity of tobacco etch virus protease.
Kapust RB; Tözsér J; Copeland TD; Waugh DS
Biochem Biophys Res Commun; 2002 Jun; 294(5):949-55. PubMed ID: 12074568
[TBL] [Abstract][Full Text] [Related]
15. Characterization of aromatic residue-controlled protein retention in the endoplasmic reticulum of
Mei M; Zhai C; Li X; Zhou Y; Peng W; Ma L; Wang Q; Iverson BL; Zhang G; Yi L
J Biol Chem; 2017 Dec; 292(50):20707-20719. PubMed ID: 29038295
[TBL] [Abstract][Full Text] [Related]
16. Improved solubility of TEV protease by directed evolution.
van den Berg S; Löfdahl PA; Härd T; Berglund H
J Biotechnol; 2006 Feb; 121(3):291-8. PubMed ID: 16150509
[TBL] [Abstract][Full Text] [Related]
17. Unexpected tobacco etch virus (TEV) protease cleavage of recombinant human proteins.
Beaumont LP; Mehalko J; Johnson A; Wall VE; Esposito D
Protein Expr Purif; 2024 Aug; 220():106488. PubMed ID: 38679188
[TBL] [Abstract][Full Text] [Related]
18. Directed evolution improves the catalytic efficiency of TEV protease.
Sanchez MI; Ting AY
Nat Methods; 2020 Feb; 17(2):167-174. PubMed ID: 31819267
[TBL] [Abstract][Full Text] [Related]
19. Directed evolution of the 3C protease from coxsackievirus using a novel fluorescence-assisted intracellular method.
Meister SW; Hendrikse NM; Löfblom J
Biol Chem; 2019 Feb; 400(3):405-415. PubMed ID: 30521472
[TBL] [Abstract][Full Text] [Related]
20. Substrate profiling of tobacco etch virus protease using a novel fluorescence-assisted whole-cell assay.
Kostallas G; Löfdahl PÅ; Samuelson P
PLoS One; 2011 Jan; 6(1):e16136. PubMed ID: 21267463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
